APPROVALS ANALYSIS: Big Month For Cardio Devices, But Down Overall
This article was originally published in Clinica
April was a slow month for medical device approvals, with just 46 recorded for the month on Clinica’s Medical Devices Approvals Tracker, but it was the biggest month for PMAs and PMA supplements approved by the US FDA in more than a year.
You may also be interested in...
Boston Scientific cardiac rhythm management has been struggling to compete with MRI-compatible devices from rival Medtronic.
Several big names in medtech announced their second-quarter sales and earnings in late July and early August. Here are some of the companies that impressed investors and others that raised some doubts.
Nevro is known for its spinal cord stimulation technology but wants to help a wide range of patients with chronic pain, so it is buying Vyrsa, which offers a complete system for sacroiliac joint fusion. In and interview with Medtech Insight, Nevro CEO Kevin Thornal explained how Vyrsa supports Nevro's strategy in this growing market.